Diisopropylethylamine → HCID 67969064, compound
Reaction equation
[Br:1][C:2]1[NH:10][C:9]2[C:8](=[O:11])[N:7]([CH2:12][C:13]3[N:22]=[C:21]([CH3:23])[C:20]4[C:15](=[CH:16][CH:17]=[CH:18][CH:19]=4)[N:14]=3)[C:6]3=[N:24][CH2:25][CH2:26][N:5]3[C:4]=2[N:3]=1.CCN(C(C)C)C(C)C.Br[CH2:37][C:38]#[C:39][CH3:40]>CN(C=O)C>[Br:1][C:2]1[N:10]([CH2:37][C:38]#[C:39][CH3:40])[C:9]2[C:8](=[O:11])[N:7]([CH2:12][C:13]3[N:22]=[C:21]([CH3:23])[C:20]4[C:15](=[CH:16][CH:17]=[CH:18][CH:19]=4)[N:14]=3)[C:6]3=[N:24][CH2:25][CH2:26][N:5]3[C:4]=2[N:3]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To 2-bromo-5-((4-methylquinazolin-2-yl)methyl)-7,8-dihydro-3H-imidazo[2,1-b]purin-4(5H)-one 15 (470 mg, 1.14 mmol) in DMF (5 ml) was added Hunig's base (0.3 ml, 1.71 mmol) and 1-bromo-2-butyne (0.145 ml, 1.6 mmol) at room temperature. The mixture was stirred over night. Another 0.103 ml (1.14 mmol) of 1-bromo-2-butyne was added and stirred over night. The reaction was extracted by DCM twice, washed with NaHCO3 and brine, dried (MgSO4) and concentrated. The crude product was purified by flash chromatography (MeOH/DCM) to afford 2-bromo-3-(but-2-ynyl)-5-((4-methylquinazolin-2-yl)methyl)-7,8-dihydro-3H-imidazo[2,1-b]purin-4(5H)-one 16. 1H NMR S 8.02 (d, J=7.81, 1H), 7.90 (d, J=7.81, 1H), 7.78 (t, J=8.59, 1H), 7.54 (t, J=8.59, 1H), 5.50 (s, 2H), 5.30 (s, 2H), 5.08 (q, J=2.34, 21-1), 4.12 (t, J=9.38, 2H), 3.92 (t, 0.1=9.38, 2H), 2.89 (s, 3H), 1.79 (t, J=2.34, 3H).
Workup
- stirringstirred over night
- extractionThe reaction was extracted by DCM twice
- washwashed with NaHCO3 and brine
- dry with materialdried (MgSO4)
- concentrationconcentrated
- customThe crude product was purified by flash chromatography (MeOH/DCM)
Sources & evidence
- ORD record
- ord-6d256261c181498a9bd4c0acf9e2a7e7
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08691832B2
Reaction notes
Loading…